Instil Bio, Inc.
TIL
$28.41
$2.7010.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -32.41% | -27.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.91% | -5.86% | |||
| Operating Income | 10.91% | 5.86% | |||
| Income Before Tax | 24.13% | -137.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.13% | -137.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.13% | -137.07% | |||
| EBIT | 10.91% | 5.86% | |||
| EBITDA | 7.82% | 4.50% | |||
| EPS Basic | 24.87% | -136.84% | |||
| Normalized Basic EPS | 11.31% | 21.69% | |||
| EPS Diluted | 24.87% | -136.84% | |||
| Normalized Diluted EPS | 11.31% | 21.69% | |||
| Average Basic Shares Outstanding | 0.98% | 0.10% | |||
| Average Diluted Shares Outstanding | 0.98% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||